Genetic polymorphisms of HMGCR and related genes that reduce LDL-C also increase the probability of developing T2D [54,55], whereas patients with monogenic familial hypercholesterolaemia have high levels of hepatic cholesterol and a reduced risk of incident T2D [56,57]. This evidence concerns the gene HMGCR and type 2 diabetes mellitus.